nach oben

Erschienen in:

01.10.2022 | Clinical study

AEs in children after Pfizer-BioNTech COVID-19 vaccine

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Adverse events (AEs) after the Pfizer-BioNTech COVID-19 vaccine [BNT162b2; tozinameran] are more frequent in children with allergic diseases than in children without allergies, according to findings of a study published in the European Journal of Pediatrics. …

Yoshida M, et al. Time course of adverse reactions following BNT162b2 vaccination in healthy and allergic disease individuals aged 5-11 years and comparison with individuals aged 12-15 years: an observational and historical cohort study European Journal of Pediatrics : 21 Oct 2022. Available from: URL: https://doi.org/10.1007/s00431-022-04643-0

Titel: AEs in children after Pfizer-BioNTech COVID-19 vaccine
Publikationsdatum: 01.10.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-26270-6

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Tozinameran

Antihypotensives/heparin

Ceftazidime

Multiple drugs

Aspirin/clopidogrel

Piperacillin/tazobactam